|
|||||
|
|||||
|
Speakers
|
|||||
|
About Stellar Pharmaceuticals Stellar Pharmaceuticals Inc. has developed and is marketing three products in Canada based on its core polysaccharide technology: NeoVisc®, for the treatment of osteoarthritis, Uracyst® and the Uracyst® Test Kit, Stellar's patented technology for the diagnosis and treatment of Interstitial Cystitis (IC), an inflammatory disease of the urinary bladder wall. Stellar also has in-licensing agreements for SkeliteTM, a proprietary synthetic bone-grafting product and NMP22® BladderChek®, a proteomics-based diagnostic test for the diagnosis and monitoring of bladder cancer which are expected to positively impact sales in 2005. |
|||||
For more information on Stellar Pharmaceuticals visit the web site at www.stellarint.com.
 |
|||||
